Monday, December 22, 2025
Home Blog Page 758

Can 7Up Cure The Common Cold?

7Up has been the go-to liquid for upset stomachs for ages. If you’re of a certain age, it’s likely your mom or grandma gave you a glass of the bubbly drink when you felt nauseous. But now, it’s been hailed as a cure for the common cold. Something smells fizzy.

The soft drink is certainly a tasty beverage, but it’s healing properties are questionable. FOX News has taken this home remedy out of the closet and given it a good dusting to share with others who may be searching for an easy cure during this time of year, when the cold and flu bugs seem to outnumber healthy humans. But, as they mention, don’t believe the hype, because — surprise! — drinking clear soda (of any kind) does not actually work. Sorry, kid.

https://giphy.com/gifs/dead-dying-im-tbsyS16NFRhwQ

What does work, however, according to actual doctors (sorry, mom) is hot liquids, like tea and broth, which will help clear up congestion.

RELATED: The Link Between Cannabis Use And The Common Cold

The trick when it comes to colds is to get plenty of sleep and stay hydrated. So if you really want that glass of 7Up, try infusing water with fruit for a few hours. Sure, it won’t have that fizzy quality, but it sure will make you feel a heckuva lot better than cola! Also, for the sake of your well-being, avoid caffeine and alcohol, too.

Colds are a buzzkill.

You’ll Definitely Want These 5 Cool Tech Items From CES 2019

The Consumers Electronics Show is one of the largest platforms for developers and those who work with consumer technology. The annual convention features interesting and useful tech items that could also end up making an important imprint in the tech industry.

This year’s convention in Las Vegas showed off an impressive amount of products that tech lovers will be excited to get their hands on. From smart shoes to cameras that follow you around, here are five of CES’s weirdest and most interesting items.

Smart shoes

 

View this post on Instagram

 

A post shared by E-vone (@e.vone.shoes) on

RELATED: Gen Z Teens Are Ditching Their Smartphones For Flip Phones

French company E-Vone is developing smart shoes that notifies the user whenever they’re about to fall. It sounds like a pretty dumb invention, but people nowadays want smart everything. E-Vone shoes are available via an annual subscription of $400 a year or $35 a month. Once enrolled, the company provides you with an extra pair of shoes every year.

Super smart cameras

 

View this post on Instagram

 

A post shared by pivo (@getpivo) on

Companies like Pivo are developing new cameras that track their subjects and that don’t need someone to operate the device; a good option for people who need innovation and competent cameras, like many YouTubers and bloggers.

Smart suitcase

Nothing smarter than developing smart luggage.  Ovis Suitcase is a company that builds bags designed to follow you around at six miles per hour, no matter if you’re on the street or at the airport. These suitcases, which activate just by holding them, assist when your hands are busy or when you simply don’t want to have to think about your carry-on bag.

Air bags for motorcyclists

 

View this post on Instagram

 

A post shared by Helite Moto USA (@helitemoto) on

RELATED: 5 Ways You Can Protect Your Eyes From Overexposure To Digital Screens

Helite is designing air bags for motorcyclists and equestrians, preventing injuries from happening. These air bags are included in vests that are meant to inflate when the driver or rider is in danger, and are not meant to be activated when there’s a jump or the bike goes over a speed bump.

Earpiece translator

WT2 Translator is an earpiece that connects to your smartphone, allowing you to communicate through your preferred language and then having the device translate and play your message through your phone’s mic. The earpiece is currently priced at $219 and it’ll be sold through Amazon.

Are Cryptocurrencies The Future Of The Cannabis Industry?

The legal cannabis industry and the cryptocurrency industry appear to have a budding relationship if you’ll excuse the pun.

The two share a lot of common ground. Both operate in legally gray areas, particularly in the United States. They face many of the same challenges from financial, political, and regulatory standpoints. Their user bases could even be said to overlap, as both legal cannabis and cryptocurrency are most popular with younger demographics.

Their shared traits aside, cannabis and cryptocurrency have complementary business models that are likely to bolster one another as adoption – in both – becomes more widespread. Some companies on both sides of the aisle are already taking advantage of this natural synergy. We’re going to present a brief survey of the separate cannabis and crypto business landscapes and point out the important intersections developing between the two.

Crypto’s Challenges

The challenges facing cryptocurrency adoption are all too familiar. Despite operating in the public sphere for the better part of a decade, cryptocurrencies are still viewed as a fringe financial tool by the mainstream media, public, and financial institutions. Part of this is practical. Cryptocurrencies are relatively new if viewed from the thousand-year history of currency, and they do not yet enjoy day-to-day use anywhere outside of a few tech enclaves in Malta, Puerto Rico, and some major cities in the U.S. and Asia. They are, in a word, unfamiliar.

RELATED: Why Cryptocurrency Is Gaining Acceptance In Cannabis Industry

Few government regulatory agencies know exactly how to approach them, and even fewer businesses trust them as a secure store of value. This is partly due to their current volatility and partly due to their low adoption rate. It ends up being a bit of a vicious cycle. It’s difficult to get merchants to accept crypto because few individuals or financial institutions are willing to handle them. As a result, fewer merchants are willing to accept them and round and round the issue goes.

Then there are some very real legal issues. It’s not entirely clear whether some, all, or no cryptocurrencies qualify as securities. They are not traditional currencies, as such, and so are not treated or taxed in the same way. And they possess a technological component that sets them apart. They are stored and traded on blockchains, which offer fast, distributed, and transparent transaction chains. These advantages are a bit of a double-edged sword when it comes to regulation, however, as blockchains can transcend financial institutions, businesses, and even national borders.

The Cannabis Hurdle

Let’s just assume, for the moment, that we’re talking about portions of the world where cannabis is entirely legal. That lets us dispense, to use another pun, with all the areas where cannabis enjoys not-quite-official status – no-enforcement zones, decriminalized areas, and so on. So, we’re really talking about states, in particular, where marijuana dispensaries are all aboveboard, legal, and recognized by the U.S. government.

Even with all that official backing, cannabis dispensaries and farms face significant challenges. Few banks want to offer loans or credit to a marijuana-based enterprise due to the newness of the market and the sticky legal issues that arise when states’ rights come into play. Marijuana is still not legal on the federal level, and because banks are required by law to be federally insured, it’s not entirely clear whether they can play on an equal playing field in the marijuana industry.

This is important. It means that’s the billion-dollar, legal marijuana industry (and marijuana is now legal in two-thirds of U.S. states) must operate on a cash-only basis, much like its black-market cousin. This puts it in the same “unbanked” boat as much of the third world.

The Synergies

It’s this “unbanked” situation that really creates the potential for crypto and cannabis to come together. Cryptocurrencies have demonstrated, via their blockchain technology, that they present a viable alternative for folks unwilling or unable to secure traditional banking accounts. As originally spelled out by Bitcoin creator Satoshi Nakamoto in his landmark white paper, cryptocurrencies contain within their blockchains all the trust and information needed to bypass third-party intermediaries, like banks, entirely. Value can be stored in a distributed and open way across the blockchain, and it can be transferred without the involvement of a financial or government entity.

It’s been done before, though the comparison is likely to raise eyebrows. The first widespread adoption case for Bitcoin was actually the Silk Road black market, where drugs, guns, and other unsavory items could be bought anonymously and in an (at the time) untraceable fashion with Bitcoin.

RELATED: No, You Won’t Be Buying Marijuana With Bitcoin Anytime Soon

This association between cryptocurrencies and drugs might feel uncomfortable, at first, but they both lend each other an air of respectability in the long-run. Marijuana may be federally prescribed, but it is legal at the state level. Cryptocurrencies might get sideways glances from U.S. tax and regulatory officials, but there’s nothing inherently illegal about owning or using a Bitcoin.

Blockchain tech and cannabis seem to go hand in hand in this regard. Cannabis operators can rely on a blockchain tailored for their use as both a store of value and a transaction medium that’s more secure and easier to handle than cash. At the same time, the blockchain gets a ready-made group of adopters to display as a real-world test case. After all, if the blockchain works well for securely tracking and handling cannabis transactions, why wouldn’t it work just as seamlessly in auto, flight, or grocery transactions?

Both industries have a lot to prove, both to the public and to regulators. The blockchain is practically designed for transparent, easily accountable transactions. This gives cannabis operators some safety from government regulators looking to ensure that the product isn’t being moved into still-black markets, and it gives would-be cryptocurrencies some credibility in terms of handling large numbers of day-to-day transactions.

Early Adopters

There are several major projects currently working to wed the crypto and cannabis industries. Most of them popped into being during 2014. The five most prominent are PotCoin, CannabisCoin, DopeCoin, HempCoin, and CannaCoin. As of May 2018, none has yet achieved widespread adoption. At the moment, a new cannabis coin is being rolled out called the VapeCoin which will be accepted on one of the biggest cannabis and vape marketplaces. However, they all share the same basic use case – giving marijuana growers, distributors, and associated industries a common medium of exchange and verifiable store of value.

Tellingly, all but CannaCoin boast market caps in the millions of U.S. dollars. PotCoin, the oldest of the bunch, has a market cap of $31 million.

Growing Up Together

Both crypto and cannabis are brand-new industries. The infrastructure for both is almost nonexistent from every possible angle. In fact, neither enjoy completely legal status across the entire United States. Cannabis is currently only legal on a state-by-state basis, while the U.S. Securities and Exchange Commission has a hands-off policy with regards to cryptocurrency exchanges.

The two are likely to grow up together, so to speak. Their shared challenges create opportunities for complementary growth, particularly in the legal and regulatory arenas. Cryptocurrencies give transparency and accountability to marijuana operators. Marijuana operators create a valuable and stable customer base for cryptocurrencies, in addition to injected capital. Both are poised for growth as U.S. demographics lean increasingly left in terms of regulation. Overall, cannabis and crypto present a unique view of the future financial world.

This article originally appeared on Green Market Report.

Kamala Harris Now Supports Marijuana Legalization And Ending War On Drugs

If there was ever a sign that Sen. Kamala Harris (D-CA) is considering throwing her hat into the ring for a 2020 presidency, her new memoir is it. In many ways, The Truths We Hold: An American Dream is a campaign book designed to clear the air and position her directly on the runway towards a presidential bid. Among other things, she  addresses past controversies, but she also discusses cannabis in a way she previously has not.

“Something else it’s past time we get done is dismantling the failed war on drugs—starting with legalizing marijuana,” Harris writes, according to Forbes.

But dismantling prohibition, she adds, must be accomplished “with eyes wide open, understanding that there is unfinished business when it comes to legalization.”

RELATED: What States Will Legalize Marijuana In 2019?

These opinions reflect a reversal from Harris, who just a few years back was chuckling at questions regarding cannabis. Back in 2014, Harris was battling GOP candidate Ron Gold in a race to be California’s Attorney General. Gold heavily favored legalizing adult-use marijuana, and integrated it into part of his platform.

When a local news reporter asked Harris her thoughts on Gold’s position, she replied that “he’s entitled to his opinion,” before bursting into laughter. Just two years ago, when Californians voted to legalize adult-use cannabis, she declined support for the ballot measure.

But as more members of the Democratic party use cannabis legalization as means of gaining favor with voters, Harris, too, has changed her tune.

“We need to legalize marijuana and regulate it,” Harris writes in the book, while also highlighting racial disparities in law enforcement upholding drug laws. “And we need to expunge nonviolent marijuana-related offenses from the records of millions of people who have been arrested and incarcerated so they can get on with their lives.”

RELATED: Why New York Will Be Pushed To Legalize Marijuana Sooner Rather Than Later

Last year, Harris also supported Sen. Cory Brooker (D-NJ) and his Marijuana Justice Act, a piece of legislation that would remove cannabis from the Controlled Substances Act.

THCV: Powerful Appetite-Suppressing Cannabinoid

Cannabis is not only a medically beneficial plant, but it’s also very complex and intricate. Thus far, it has been found that the cannabis plant contains over 400 chemical entities and more than 60 of them are known as cannabinoid compounds. One of those cannabinoid compounds is Tetrahydrocannabivarin or THCV for short. This cannabinoid contains various medicinal properties that users can benefit from, and as time goes on, more medicinal properties are being revealed. Although THCV sounds and looks like THC, these cannabinoids are quite different from one another, especially because of the effects they deliver to users regarding appetite. Read on to find out more about THCV, the impact it has on one’s appetite, and which cannabis strains are high in THCV.

About THCV And Its Link To THC

To many, THCV may seem very similar to THC based on how it sounds and how it looks. Although THC and THCV have some similarities, they are also very different, especially regarding the effects they deliver to cannabis users. How is THCV similar to THC though? For one, these cannabinoids are very similar in regards to their chemical structure. Whereas, the process of creating these two cannabinoids is quite different.

RELATED: How Marijuana’s THCV Can Positively Impact Your Life

In other words, THCV undergoes a process that results in it becoming a cannabigerovarin acid (CBGVA). Then, CBGVA breaks down into tetrahydrocannabivarin carboxylic acid (THCVA). From here, THCVA can undergo a decarboxylation process in which UV light or heat is used to create THCV.

In addition, both THC and THCV activate specific receptors within our body. These main receptors are known as CB1 and CB2. THC and THCV impact the same receptors, however, it’s important to know that this response works as an antagonist of both CB1 and CB2 receptors. Since THCV is an antagonist of the CB1 and CB2 receptors, this means that THCV blocks THC, which prevents cannabis users from getting the munchies.

THCV’s Appetite-Suppressing Properties

Furthermore, as many of you may already know, we all have an endocannabinoid system (ECS), and it’s a very complex system that regulates different functions within the body. One particular function that the ECS regulates is the body’s appetite. Research indicates that the munchies (the feeling cannabis users experience after their appetite is stimulated) is due to a response in the ECS. Over time, different research findings have pointed to THC’s ability to boost one’s appetite and act as an appetite stimulant.

Although THC is known to stimulate the appetite of users, THCV has the opposite effect. Rather than THCV stimulating users’ appetite, it suppresses one’s appetite. Since THCV is an antagonist of the CB1 and CB2 receptors, it blocks THC. Therefore, users don’t experience the munchies after consuming THCV. Other research findings point to THCV removing the satiating/pleasing feeling that sometimes occurs after eating something delicious.

With this being said, individuals who have been diagnosed with certain eating disorders and/or individuals who struggle with obesity and need to regulate their food intake better may be ideal candidates for THCV consumption.

Cannabis Strains High In THCV & THCV’s Effects

Aside from THCV’s appetite-suppressing properties, it possesses other medicinal benefits such as it acting as an effective anti-convulsive cannabinoid. Thus, THCV could potentially be used to raise the seizure threshold for individuals with epilepsy and seizure disorders. Also, it has recently been discovered that THCV contains a strong potential in assisting type 2 diabetics by helping control glycemic levels, according to one 2016 study.

The medicinal benefits don’t stop here though. THCV could even help manage body tremors while also improving motor control abilities. However, additional studies and clinical trials should be performed before individuals start consuming THCV to help manage body tremors.

RELATED: 6 Of The Most Helpful CBD Products

Moreover, after THCV consumption, this cannabinoid typically causes a fast onset of psychedelic-related effects that deliver clearheaded-ness to users, which wears off relatively quickly. If one wants to consume THCV, which strains are the best? Oftentimes, THCV is found in different sativa dominant cannabis strains. Some of the top cannabis strains that contain high levels of THCV include the following: Durban Poison, Girl Scout Cookies, Cherry Pie, Face off OG, Jack the Ripper, Doug’s Varin, and Pineapple Purps.

As time goes on, more of THCV’s medicinal properties are being revealed. However, the main medical benefit of THCV that has captured many people’s attention and continues to do so is its appetite-suppressing properties. Overall, there’s a significant potential for how THCV could positively impact people’s lives, especially for those who need help managing their appetite and food intake. Do you think the consumption of THCV will increase in the years to come? Stay tuned to find out how THCV progresses and evolves in this rapidly-changing industry.

No One Will Shut Up About The New Bachelor Being A Virgin

0

It’s a new year and a new bachelor, this time a 26-year-old hot guy who’s a virgin. After the show’s three hour season premiere last night, it’s obvious that the host and the 30 contestants can’t make their peace with this fact.

Since before the season’s release, ABC has been capitalizing on Colton Underwood’s virginity, mentioning this fact four times in the minute-and-a-half season trailer. It’s one of the season’s biggest plot points and producers are betting that it’ll be the biggest hook.

RELATED: Contestants From ‘The Bachelor: Vietnam’ Dump Bachelor For Each Other

While “The Bachelor” isn’t a show known for its nuance and awareness when it comes to gender politics, it’s still shocking to see the amount of energy that producers have spent on letting viewers know how weird it is that Colton is a virgin by choice. “I’m not waiting for a ring, I’m not waiting for marriage, I’m waiting to be in love, I’m waiting for it to feel right,” he explained on the season premiere.

The first three hours of the beloved reality TV show dove deep into the reasons behind Underwood’s virginity, with host Chris Harrison claiming that a man who’s a virgin isn’t really a man.

Harrison: “How much of the negativity and the ‘he’s not ready’ has to do with your virginity?”

Uderwood:  “That’s sort of the stigma around being a virgin. Oh, he’s not romantic. Oh, he’s not going to be a good bachelor—”

Harrison: “He’s not a man.”

RELATED: How Sex Is Manufactured On Shows Like ‘Bachelor in Paradise’

Although there have been other virgins featured in “The Bachelor” franchise, this is the first time the protagonist holds the coveted/much maligned role. Fans of the reality show should get ready and build up their tolerance for virgin jokes that were funny when they were in high school.

Sorry, But Malcolm Gladwell Is Plain Wrong About Marijuana

I met Malcolm Gladwell once. Working at one of the Austin coffee shops I frequent, I overheard that distinct voice of his—a reassuring, rigorous tone that his prose also embodies. Eventually I approached him, commenting how I enjoyed his work, but he seemed busy, not really looking to engage, as was his right. Polite, but not altogether genial, if I had to characterize the interaction.

Now, I only write that to clarify I don’t think he’s a bad guy. But he seems quite lost in the weeds when it comes to cannabis. In a recent New Yorker feature titled “Is Marijuana As Safe As We Think It Is?”, Gladwell posits significant concern over the public’s embrace of cannabis. He cites lack of research on marijuana’s myriad effects and compounds, while also worrying about the increasing potency of commercial cannabis, and how its usage could link to rises in schizophrenia and violence.

What has drawn the ire of cannabis activists and public health advocates across the internet is how Gladwell seemingly mistakes correlation for causation—or at least his winking suggestion of such conclusions—and how the scope of his story seems written with blinders on, altogether ignoring significant context or contrarian evidence to the research he highlights.

RELATED: Why Does Smart Guy Malcolm Gladwell Reject Marijuana Legalization?

Here at The Fresh Toast we’ve exposed both sides of the argument: that marijuana may work to trigger psychosis in some while also questioning the cause-and-effect relationship between cannabis and schizophrenia cases. “Researchers have to tread carefully in evaluating the evidence and avoiding scaremongering,” Musa Sami, Researcher and Academic Psychiatrist at King’s College London, wrote on this site.

You should also know that anyone within the cannabis industry worth their salt has expressed to me a need for more research on cannabis and a tempering of expectations that cannabis might be a miracle penicillin. Even the National Center for Complementary and Integrative Health has made open calls for more cannabis research. In other words, shouting the need for more cannabis research is not a revolutionary stance.

Gladwell, however, doesn’t tell you why more significant research on cannabis hasn’t occurred. Because the federal government classifies cannabis as a Schedule I drug, universities and institutions hoping to study cannabis in a clinical trial must first acquire approval from three different government agencies: the Drug Enforcement Agency, the Food and Drug Administration, and the National Institute on Drug Abuse. In addition, scientists studying cannabis have long battled an additional loophole their colleagues focused on other Schedule I drugs—like LSD or MDMA—do not face. For the past 50 years scientists could only use cannabis grown from NIDA at the University of Mississippi. The problem? The federal pot farm was delivering unusable moldy samples.

Thanks to a crusade from Rep. Matthew Gaetz (R-FL), that should soon change. Gaetz sponsored the Medical Cannabis Research Act, which forces the government to hand out more cultivation licenses for marijuana to be used in scientific research. This is an improvement, but the irony is a Colorado-based researcher cannot simply run to the store, buy some weed, and use it for research. They must jump through many hoops, like Arizona-based Dr. Sue Sisley did only to receive the moldy weed she did.

RELATED: Using Medical Marijuana For Anxiety Relief: The Dose Is Key

This is why some American researchers have demonstrated jealousy over their Canadian brethren. Because of all the limitations I’ve laid out, many Americans researchers conduct observational studies—meaning they follow subjects already using cannabis while asking them questions or to perform certain tasks, then develop findings from there. It’s not an exact science. Thanks to Canada legalizing cannabis, it’s opening a treasure trove of data for Canadian researchers to dig through and develop more conclusive findings. Seriously, Canadian scientists are downright giddy over their newfound opportunities to conduct the research they’ve long hoped to do.

“It’s super exciting,” Sean Myles, research chair in Dalhousie University’s Department of Plant, Food, and Environmental Sciences, told Motherboard. “Like, this never happens. All of a sudden, there’s an organism on the planet that’s worth a tremendous amount, that nobody knew anything about, and you’re allowed to investigate it with some pretty deep pockets behind it.”

Here is where it’s probably worth mentioning that Malcolm Gladwell is Canadian.

RELATED: You Have The Highest THC Strain — So What?

Much of Gladwell’s story revolves around a new anti-marijuana book from Alex Berenson, a former investigative reporter at the New York Times. It’s titled Tell Your Children: The Truth About Marijuana, Mental Illness, and Violence. Worth noting for you non-cannabis historians out there: Tell Your Children was the original title for the 1930s anti-cannabis propaganda film Reefer Madness. The book was released today and has enjoyed one hell of a press rollout.

In interviews, Berenson makes claims about medical marijuana users like “nearly all were recreational users before they became ‘patients’” and “medical legalization is simply a backdoor way to protect recreational users from arrest.” His book is quoted liberally, whether it’s being directly cited or not, in Gladwell’s piece, as one journalist pointed out.

https://twitter.com/davelevitan/status/1082680433689706498

https://twitter.com/davelevitan/status/1082690921395900416

This whole backlash has raised questions about Malcolm Gladwell being a “tobacco industry shill.” That label originated with  a 1990 Washington Post article Gladwell wrote titled “Not Smoking Could Be Hazardous to Pension System.” But the accusation gained momentum, however, when a S.H.A.M.E. article demonstrated Gladwell’s possible ties to Big Pharma and Big Tobacco. To his credit, Gladwell recently responded to the controversy.

“I have been staunchly anti-tobacco for as long as I’ve lived,” Gladwell wrote in an email to the Huffington Post. “I’ve never smoked. No one in my family smokes. I hate smoking. (I’m a runner, for goodness sake.) I am someone who is passionate about the dangers of smoking. It’s something I have cared about for years—and I’ve attempted to write about the issue with intelligence and insight. For these morons to come along and somehow maintain that I am sympathetic to big tobacco is beyond offensive.”

RELATED: 6 Essential Facts To Know About Marijuana Edibles Before Indulging

You’re free to draw your own conclusions there. Personally, I don’t consider Gladwell a shill or a hack by any means. However, it seems Gladwell has been taken in by Berenson’s book, because of, if for no other reason, its research underpinnings support Gladwell’s position on cannabis. While plenty of other research exists out there to showcase marijuana’s positive medical benefits and what scientists are saying about cannabis, it appears you won’t hear them from Gladwell.

4 Ways The New Royal Baby Will Make History

Meghan Markle and Prince Harry are expecting the monarchy’s newest member soon (some speculate as early as March).  Not only will the baby be born to a mother considered to be the first person of African decent to marry into the royal family (not to mention the first American actress), Good Housekeeping compiled a list of other ways this baby is going to be an exceptional addition to the Royal Family. Here are 4 ways little baby Sussex will make history.

U.S. citizenship 

Since Meghan is an American who has lived in the U.S. for a minimum of five years, her offspring qualifies for U.S. or dual citizenship. However, it’s ultimately in the best interest of the royal family that Meghan ditch her passport, since remaining a U.S. citizen could put them at risk for an IRS audit.

RELATED: 5 Strange Pregnancy Rules Meghan Markle Has To Follow

Home birth

Although home births are not exactly preferred within the Royal Family, it’s rumored that Meghan could opt for the untraditional birthing method. Back in the day, home births were very common among royals. In fact, Prince William was the first royal heir to be born in a hospital in 1982. Since then, it’s protocol that royals give birth at the Lindo Wing of St. Mary’s Hospital, which is basically like the penthouse suite at the Four Seasons. But sources told Vanity Fair that Meghan and Harry are considering other options for the birth of their first child,

History-making title

If baby Sussex turns out to be a girl, she could overturn the patriarchy with a title that’s never been given to a female member of the Royal Family: Duke. According to TIME, five women have filed a case with the European Court of Human Rights asserting that women should be allowed to inherit dukedoms, too. We’ll have to wait and see if this old crusty law gets overturned, but if it does, the new baby could potentially become the first “Duke.”

RELATED: Inside The Private Suite Where Kate Middleton Will Give Birth

New home

The baby will be the first newborn to live in Frogmore Cottage, where his or her parents will soon reside full-time. The Queen gifted the home to the newlyweds shortly after they got married in May 2018.

Where Does Presidential Candidate Elizabeth Warren Stand On Marijuana?

0

Toward the end of last year, Senator Elizabeth Warren of Massachusetts announced that she was contemplating a presidential run in 2020. Considering the controversy stirred over the past couple of years by President Trump, this potential bid for the Democratic nomination appears to be a nicely timed political move. Still, some question whether Warren isn’t “likable” enough to win the hearts of the American people.

It doesn’t hurt, however, that she has become a relatively strong voice for marijuana reform in the United States. Now that well over 60 percent of the population supports the concept of legal weed, the next presidential candidates, regardless of whether they are a man, woman, Democrat or Republican, will need to be on board with ending prohibition across the nation or else run the risk of getting snuffed out.

RELATED: Elizabeth Warren Reveals How Jeff Sessions ‘Catalyzed’ Marijuana Legalization 

But just how far would Warren go with pot reform if elected? And is it enough to go toe-to-toe with Trump’s flighty support on the issue?

Although Warren says she has never smoked marijuana, she is all for pot reform. The last major piece of legislation the lawmakers cozied up to was called the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act. The bill was designed to remove federal controls from those states that legalized marijuana.

The measure wouldn’t legalize marijuana nationwide, but it would keep Uncle Sam’s nose out of the scene enough to allow cannabis banking solutions and eliminate the possibility of any kind of federal crackdown – no matter how unlikely such a thing is at this juncture. “The federal government needs to get out of the business of outlawing marijuana,” she said last year in a statement regarding the STATES Act.

But it appears Warren would go all the way on the issue. She is also connected to the Marijuana Justice Act, which would legalize marijuana at the national level and lead to the expungement of criminal records associated with certain degrees of marijuana offenses.

Still, it has become clear that protecting the rights of states to legalize marijuana is most important factor right now. Warren understand this.

Last year, back when former Attorney General Jeff Sessions took his disdain for marijuana a step further by rescinding an Obama-era memo (Cole) put into place to allow states to experiment with marijuana legalization, Warren was part of a campaign demanding the memo be restored. The communication asserted that giving states this assurance would “create a pathway to a more comprehensive marijuana policy that respects state interests and prerogatives.”

RELATED: Watch Elizabeth Warren’s Video Supporting Cannabis Law Reform

Some Democratic lawmakers believe President Trump might use marijuana reform to secure the election in 2020. During his first campaign, Trump said that he was in favor of medical marijuana and believed legalization should be left up to individual states. Still, Trump is responsible for putting cabinet members in place that has made it difficult for the cannabis trade to operate with ease. The best we’ve gotten from him so far was earlier last year when he told reporters that he would “probably” sign the STATES Act if it crossed his desk. But as much as he flips on his word, it would be nothing for him to come out all of a sudden in favor of full-blown legalization.

It’s still too early to tell how the marijuana legalization issue will fit in with the 2020 election.

If she would happen to snatch the Democratic nomination, Senator Elizabeth Warren could end up being a favorite. New York Times columnist Krugman wrote this week that while he isn’t sure she deserves to be president, “she is what a serious policy intellectual looks and sounds like in 2019.”

European Union Laying Groundwork For Legalizing Medical Marijuana

Medicinal cannabis is creeping up the European Union agenda as legislators prepare to divert cash into research of the drug and begin laying the groundwork for a harmonized set of laws across the bloc.

Health committee politicians in the European Parliament, the EU’s directly elected legislative, voted in late 2018 to approve a draft resolution on the use of cannabis for medicinal purposes, and now the proposals will head to the bloc’s executive to be turned into a concrete proposal.

The file has been added to the ‘work in progress’ calendar, and from January 14 EU officials will begin a formal study of the potential clinical benefits of medicinal cannabis and cannabis-derived medicines, and how they are available to patients across Europe.

RELATED: The Growth Of Cannabis Legalization In Europe: Which Country Is Next?

Europe’s cannabis industry is predicted to be worth €115.7bn ($132bn) by 2028, making it the world’s largest legal marijuana market. A patchwork of domestic regulations means the EU could not legalize cannabis in one fell swoop, but it can lay down a set of guidelines that each country transposes into domestic law.

The EU has 28 member states, each with their own set of cannabis laws. Some jurisdictions, such as the Netherlands, have decriminalized the drug, while others have a more draconian approach and will jail anyone found in possession.

This blog has already looked at the situation in Germany, Malta, Italy, the UK and Irelandamongst other areas taking steps towards cultivating their own cannabis industries, with Portugal and the Scandinavian territories also moving to a more progressive stance.

Now it appears the EU’s lawmakers are waking up to the health, and tax benefits, of allowing cannabis for medicinal purposes at least, and attempting to draw up a set of rules for the bloc that will give a platform for trade.

In December, the EU’s drug agency, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), slipped out its first report on medicinal cannabis.

It sought to answer the evidence base for the use of cannabis and cannabinoids in modern medicine, alongside providing definitions of cannabis preparations and medicinal products, and the differences between both.

Aimed at policymakers, the report responds to growing interest in this topic as more European countries develop policies and practice in this area.

RELATED: How Swiss Marijuana Reform Will Lead To Full Legalization In Europe

“Many EU countries now allow or are considering allowing, the medical use of cannabis or cannabinoids in some form,” the report states. But approaches vary widely between countries, both in terms of the products permitted and the regulatory frameworks governing their provision, it notes.

The report also outlines the terms “medical use of cannabis and cannabinoids” can refer to a wide variety of products and preparations that may contain different active ingredients and use different routes of administration.

Source: EMCDDA

 

The publication also provides an overview of evidence for the medical use of cannabis and cannabinoids.

Source: EMCDDA

It concludes, in a similar vein to the EU’s health portfolio holders, that more research and clinical studies are needed to fill “important gaps in the evidence”.

From the US and Canada to Australia and Israel, the report presents a selection of case studies illustrating the diverse approaches used by countries outside the EU to allow the medical use of cannabis.

The report highlights the challenges of decision-making and summarises the multiple issues that governments will consider when deciding whether to make cannabis or cannabinoids available for medical use.

These include the types of product that patients will be allowed to use; the medical conditions for which such products can be used; and the type of medical and regulatory supervision under which patients are allowed to use them.

“In most countries, the provision of cannabis and cannabinoid products and preparations for medical purposes has evolved over time, often in response to patient demand or product development,” said EMCDDA director Alexis Goosdeel. “This report seeks to provide an objective look at current evidence, practice, and experience in this very fast-moving field and describe the complex patchwork of approaches adopted in the EU and beyond.”

It also points to the importance of developing a common language to help build a base for evaluation and assessment, which is EU shorthand for ensuring everyone has the same definition of key points when the regulation is eventually drafted.

This article originally appeared on Green Market Report.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.